Jpmorgan Chase & CO Balchem Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Balchem Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 458,986 shares of BCPC stock, worth $83.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
458,986
Previous 451,265
1.71%
Holding current value
$83.7 Million
Previous $69.5 Million
16.22%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding BCPC
# of Institutions
373Shares Held
28.3MCall Options Held
267KPut Options Held
5.7K-
Black Rock Inc. New York, NY4.9MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$715 Million0.01% of portfolio
-
Apg Asset Management N.V. Amsterdam, P72.77MShares$505 Million3.1% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.36MShares$247 Million1.18% of portfolio
-
State Street Corp Boston, MA1.23MShares$225 Million0.01% of portfolio
About BALCHEM CORP
- Ticker BCPC
- Exchange NASDAQ
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 32,120,600
- Market Cap $5.86B
- Description
- Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...